Prospective, Phase 3, Randomized, Multi-center, Double-blind, Double-dummy Study of Efficacy, Tolerability & Safety of Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Treatment of cUTI in Adults

Trial Profile

Prospective, Phase 3, Randomized, Multi-center, Double-blind, Double-dummy Study of Efficacy, Tolerability & Safety of Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Treatment of cUTI in Adults

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Jul 2018

At a glance

  • Drugs Sulopenem (Primary) ; Sulopenem (Primary) ; Amoxicillin/clavulanic acid; Ciprofloxacin; Ertapenem; Probenecid
  • Indications Pyelonephritis; Urinary tract infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Iterum Therapeutics
  • Most Recent Events

    • 27 Jun 2018 Planned End Date changed from 1 Oct 2019 to 1 Dec 2019.
    • 27 Jun 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Oct 2019.
    • 25 Nov 2017 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top